BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7730808)

  • 21. Repression of p53 transcriptional activity by the HPV E7 proteins.
    Massimi P; Banks L
    Virology; 1997 Jan; 227(1):255-9. PubMed ID: 9007083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells.
    Suprynowicz FA; Disbrow GL; Krawczyk E; Simic V; Lantzky K; Schlegel R
    Oncogene; 2008 Feb; 27(8):1071-8. PubMed ID: 17704805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transformation assays for HPV oncoproteins.
    Massimi P; Banks L
    Methods Mol Med; 2005; 119():381-95. PubMed ID: 16350412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of the human papillomavirus E7 oncogene during cell transformation is sufficient to induce susceptibility to lysis by activated macrophages.
    Banks L; Moreau F; Vousden K; Pim D; Matlashewski G
    J Immunol; 1991 Mar; 146(6):2037-42. PubMed ID: 1848576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
    Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
    Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of human papillomavirus type 16 E6 and E7 oncogenes on the activity of the transforming growth factor-beta2 (TGF-beta2) promoter.
    Murvai M; Borbély AA; Kónya J; Gergely L; Veress G
    Arch Virol; 2004 Dec; 149(12):2379-92. PubMed ID: 15290353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The human papillomavirus type 16 E5 protein modulates phospholipase C-gamma-1 activity and phosphatidyl inositol turnover in mouse fibroblasts.
    Crusius K; Kaszkin M; Kinzel V; Alonso A
    Oncogene; 1999 Nov; 18(48):6714-8. PubMed ID: 10597278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The biochemical and biological functions of human papillomavirus type 16 E5 protein.
    Tsai TC; Chen SL
    Arch Virol; 2003 Aug; 148(8):1445-53. PubMed ID: 12898324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming activity of the E6 gene of HPV-11gt in NIH 3T3 and REF 52 cells: correlation with the level of E6 transcription.
    Trujillo JM; Mounts P
    Virology; 1996 Jun; 220(1):1-9. PubMed ID: 8659100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of the functional difference between human papillomavirus type 6 and 16 E7 proteins by their 30 N-terminal amino acid residues.
    Takami Y; Sasagawa T; Sudiro TM; Yutsudo M; Hakura A
    Virology; 1992 Feb; 186(2):489-95. PubMed ID: 1310180
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus type 16 E6 and E7 cooperate to increase epidermal growth factor receptor (EGFR) mRNA levels, overcoming mechanisms by which excessive EGFR signaling shortens the life span of normal human keratinocytes.
    Akerman GS; Tolleson WH; Brown KL; Zyzak LL; Mourateva E; Engin TS; Basaraba A; Coker AL; Creek KE; Pirisi L
    Cancer Res; 2001 May; 61(9):3837-43. PubMed ID: 11325860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the influences of the E5 transforming protein on kinetic parameters of epidermal growth factor binding and metabolism.
    Waters CM; Overholser KA; Sorkin A; Carpenter G
    J Cell Physiol; 1992 Aug; 152(2):253-63. PubMed ID: 1639860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of cell transformation by papillomavirus E5 proteins.
    DiMaio D; Mattoon D
    Oncogene; 2001 Nov; 20(54):7866-73. PubMed ID: 11753669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ErbB4 (JM-b/CYT-1)-induced expression and phosphorylation of c-Jun is abrogated by human papillomavirus type 16 E5 protein.
    Chen SL; Lin ST; Tsai TC; Hsiao WC; Tsao YP
    Oncogene; 2007 Jan; 26(1):42-53. PubMed ID: 16819515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation.
    Fehrmann F; Laimins LA
    Oncogene; 2003 Aug; 22(33):5201-7. PubMed ID: 12910257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E5 can be expressed in anal cancer and leads to epidermal growth factor receptor-induced invasion in a human papillomavirus 16-transformed anal epithelial cell line.
    Wechsler EI; Tugizov S; Herrera R; Da Costa M; Palefsky JM
    J Gen Virol; 2018 May; 99(5):631-644. PubMed ID: 29624161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
    Armstrong DJ; Roman A
    Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transformation of primary BRK cells by human papillomavirus type 16 and EJ-ras is increased by overexpression of the viral E2 protein.
    Lees E; Osborn K; Banks L; Crawford L
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():183-93. PubMed ID: 2154535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Notch1 can contribute to viral-induced transformation of primary human keratinocytes.
    Lathion S; Schaper J; Beard P; Raj K
    Cancer Res; 2003 Dec; 63(24):8687-94. PubMed ID: 14695182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hallmarks of HPV carcinogenesis: The role of E6, E7 and E5 oncoproteins in cellular malignancy.
    Estêvão D; Costa NR; Gil da Costa RM; Medeiros R
    Biochim Biophys Acta Gene Regul Mech; 2019 Feb; 1862(2):153-162. PubMed ID: 30707946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.